Hi there,

This month, Democracy Now! marks 29 years of fearless independent journalism. Presidents have come, gone and come back again, but Democracy Now! remains, playing the same critical role in our democracy: shining a spotlight on corporate and government abuses of power and raising up the voices of scholars, advocates, scientists, activists, artists and ordinary people working for a more peaceful and just world. If our journalism is important to you, please donate today in honor of our 29th anniversary. Every dollar makes a difference. Thank you so much.

Democracy Now!

Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.

Donate

FDA Approves New COVID-19 Booster Shots

HeadlineSep 12, 2023

Here in the United States, the Food and Drug Administration has approved new COVID-19 booster shots for people as young as 6 months old, with vaccinations set to begin as soon as this week. The vaccines produced by Pfizer and Moderna have been reformulated against an Omicron coronavirus subvariant that was dominant when the shots were selected by the FDA in June. The vaccines are the first COVID shots not to be purchased by the federal government. Most health insurance plans, including Medicare, will cover the cost of the vaccines; meanwhile, the CDC will administer a program to cover the cost of vaccinating people without insurance or whose plans won’t cover the shots.

This month the World Health Organization warned of a “concerning” rise in COVID-19 cases ahead of winter in the Northern Hemisphere.

Maria Van Kerkhove: “But hospitalizations are increasing in the Americas, in Europe, in what we call our Southeast Asia region, and that is of worry, given that when we get to colder months in some countries, people tend to spend more times indoors aggregated together, and viruses that transmit through the air, like COVID, will take advantage of that.”

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Top